MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory Disease
type: MedicalStudy
description: A Phase II Study of MGCD0103 (MG-0103) in Patients With Acute Myelogenous Leukemia/High Risk MDS Who Are Elderly and Have Previously Untreated Disease or Who Are Adult and Have Relapsed/Refractory Disease
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2006-09
end date: 2008-09
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00374296
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Mirati Therapeutics Inc.
study subject: Myelogenous Leukemia, Acute
study subject: Myelodysplastic Syndromes
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Myelogenous Leukemia, Acute
keywords: Myelodysplastic Syndromes

AI Analytics
type: Organization